More than half of all American adults, almost 137 million people, could be candidates for the blockbuster GLP-1 drug ...

Pharmacies that make customized medications are asking the federal Food and Drug Administration to protect their right to ...

As millions patients struggled to fill their prescriptions for the new weight loss drugs, many have turned to compounded copies.

The FDA’s decision to allow the compounding of GLP-1 weight loss drugs could undermine its public health obligations, writes ...

It sounds great, considering the cost of brand-name drugs ... of new form of mpox in a traveler You will likely see ...

The use of diabetes and weight-loss medications like Ozempic or Wegovy—called GLP-1 drugs—has exploded in recent years, with ...

More than half of all adults in the U.S. are eligible for semaglutide (Ozempic, Wegovy, Rybelsus), researchers estimated.

The Ipsos survey of 1,078 adults found 24% of people would use weight-loss jabs if they were provided for free by the health ...

Novo Nordisk launches its weight-loss drug Wegovy in China after approval by local health authorities in June.

By now, we’ve all heard of the GLP-1 diabetes and weight-loss drugs from the likes of Eli Lilly (LLY) and Novo Nordisk (NVO).

Novo Nordisk has launched its weight-loss drug Wegovy in China after it was approved by local health authorities in June.

A surprise amount of Brits say they would take anti-obesity drugs if they were given to them for free on the ...